Strategic Initiative

Slingshot members are tracking this corporate initiative:

Karyopharm (KPTI) has entered into a royalty agreement with HealthCare Royalty Partners (HCR) for up to $150M to support the development and commercialization of XPOVIO (selinexor)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
KPTI

100%
HCR

100%

Additional Information

https://investors.ka...
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Sep 16, 2019
Projected Implementation:
Q3, 2019
Relevance Tracked Until:
Q3, 2021
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Xpovio, Selinexor